当前位置:
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill
Cancer Cell ( IF 50.3 ) Pub Date : 2021-11-04 , DOI: 10.1016/j.ccell.2021.10.011 Florian Uhlitz 1 , Dmitriy Zamarin 2
中文翻译:
振兴卵巢癌中功能失调的 T 细胞:CD28 是杀死的许可证
更新日期:2021-12-13
Cancer Cell ( IF 50.3 ) Pub Date : 2021-11-04 , DOI: 10.1016/j.ccell.2021.10.011 Florian Uhlitz 1 , Dmitriy Zamarin 2
Affiliation
High-grade serous ovarian cancers (HGSOCs) exhibit limited response to immune checkpoint blockade. In a new study in Cancer Cell, Duraiswamy et al. highlight intratumoral CD28 co-stimulation by myeloid-antigen-presenting cells as a key mechanism required for activation of programmed cell death receptor 1 (PD-1)+ tumor-infiltrating T lymphocytes during PD-1 blockade in HGSOC.
中文翻译:
振兴卵巢癌中功能失调的 T 细胞:CD28 是杀死的许可证
高级别浆液性卵巢癌 (HGSOCs) 对免疫检查点阻断反应有限。在癌细胞的一项新研究中,Duraiswamy 等人。突出显示髓样抗原呈递细胞的肿瘤内 CD28 共刺激是HGSOC 中 PD-1 阻断期间激活程序性细胞死亡受体 1 (PD-1) +肿瘤浸润性 T 淋巴细胞所需的关键机制。